PT - JOURNAL ARTICLE AU - Maria Beatrice Zazzara AU - Rose S. Penfold AU - Amy L. Roberts AU - Karla A. Lee AU - Hannah Dooley AU - Carole H. Sudre AU - Carly Welch AU - Ruth C. E. Bowyer AU - Alessia Visconti AU - Massimo Mangino AU - Maxim B. Freydin AU - Julia S. El-Sayed Moustafa AU - Kerrin Small AU - Benjamin Murray AU - Marc Modat AU - Jonathan Wolf AU - Sebastien Ourselin AU - Finbarr C. Martin AU - Claire J. Steves AU - Mary Ni Lochlainn TI - Delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults AID - 10.1101/2020.06.15.20131722 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.15.20131722 4099 - http://medrxiv.org/content/early/2020/06/17/2020.06.15.20131722.short 4100 - http://medrxiv.org/content/early/2020/06/17/2020.06.15.20131722.full AB - Background Frailty, increased vulnerability to physiological stressors, is associated with adverse outcomes. COVID-19 exhibits a more severe disease course in older, co-morbid adults. Awareness of atypical presentations is critical to facilitate early identification.Objective To assess how frailty affects presenting COVID-19 symptoms in older adults.Design Observational cohort study of hospitalised older patients and self-report data for community-based older adults.Setting Admissions to St Thomas’ Hospital, London with laboratory-confirmed COVID-19. Community-based data for 535 older adults using the COVID Symptom Study mobile application.Subjects Hospital cohort: patients aged 65 and over (n=322); unscheduled hospital admission between March 1st, 2020-May 5th, 2020; COVID-19 confirmed by RT-PCR of nasopharyngeal swab. Community-based cohort: participants aged 65 and over enrolled in the COVID Symptom Study (n=535); reported test-positive for COVID-19 from March 24th (application launch)-May 8th, 2020.Methods Multivariate logistic regression analysis performed on age-matched samples from hospital and community-based cohorts to ascertain association of frailty with symptoms of confirmed COVID-19.Results Hospital cohort: significantly higher prevalence of delirium in the frail sample, with no difference in fever or cough. Community-based cohort :significantly higher prevalence of probable delirium in frailer, older adults, and fatigue and shortness of breath.Conclusions This is the first study demonstrating higher prevalence of delirium as a COVID-19 symptom in older adults with frailty compared to other older adults. This emphasises need for systematic frailty assessment and screening for delirium in acutely ill older patients in hospital and community settings. Clinicians should suspect COVID-19 in frail adults with delirium.Competing Interest StatementThe app was developed by Zoe Global Limited with input from King's College London and Massachusetts General Hospital. The Principal Investigator and corresponding author (MNL) had full access to all the data in this study and takes full responsibility for the integrity of the data and the accuracy of data analysis. All authors listed were responsible for aspects of study design, data collection and analysis and writing of manuscript and meet criteria for authorship. MBZ, RSP, ALR, CW, HD and MNL were involved in data collection, cleaning and statistical analysis of the hospital dataset. BM produced the data cleaning script for the app dataset. ALR, KAL, CHS, RCEB, AV, MM, MBF, JSESM, KS, MM, JW and SO were involved in data collection, processing and analysis of the app dataset. MBZ, RSP, ALR, KAL, HD, CHS, CW, RCEB, AV, MM, FCM, CJS and MNL drafted the initial manuscript. All authors contributed to and reviewed the final manuscript to be published. We would like to acknowledge the following COVIDCollab collaborators, responsible for hospital data collection: Rishi Iyer, Rachael Anders, Lindsay Hennah, Gitanjali Amaratunga, Abigail Hobill, Cassandra Fairhead, Amybel Taylor, Henry Maynard, Marc Osterdahl, Maria Dias, Taha Amir, Natalie Yeo, Jamie Mawhinney, Hamilton Morrin, Li Kok, Luca Scott, Aiden Haslam, Gavriella Levinson, Stephanie Mulhern, Stephanie Worrall, Thurkka Rajeswaran, Katherine Stamboullouian, Sophie McLachlan, Karla Griffith, Daniel Muller, Alice O' Doherty, Baguiasri Mandane, Irem Islek, Alexander Emery, John Millwood-Hargrave, Andra Caracostea, Laura Bremner, Arjun Desai, Aneliya Kuzeva, Carolyn Akladious, Mettha Wimalasundera, Mairead Kelly, Sally Aziz, Sinead O'Dwyer, Rupini Perinpanathan, Anna Barnard, Nicole Hrouda, Ismini Panayotidis, Nirali Desai, Hannah Gerretson, Rebecca Lau, Zaynub Ghufoor, Hanna Nguyen, Torben Heinsohn, Jack Cullen, Eleanor Watkins, Vaishali Vyas, Daniel Curley, Niamh Cunningham, Vittoria Vergani, Kelvin Miu, Jack Stewart, Nicola Kelly, Lara Howells, Benyamin Deldar, Ross Sayers, Gracie Fisk, Sri Sivarajan, Tahmina Razzak, Helen Ye, Samiullah Dost, Nikhita Dattani, Catherine Wilcock, Gabriel Lee, Jodie Acott, Hannah Bridgwater, Antia Fernandez, Hesham Khalid, Katherine Hopkinson, Deirdre Green, Hejab Butt, Ayushi Gupta, Madeleine Garner, Hazel Sanghvi, Madeleine Daly, Emily Ross-Skinner, Shefali Patel, Danielle Lis. (All affiliated to Guy's and St Thomas' Hospital NHS Foundation Trust). Written permission obtained to include the names of all individuals listed. The authors acknowledge use of the research computing facility at King's College London, Rosalind (https://rosalind.kcl.ac.uk).Funding StatementSupport for this study was provided by the NIHR-funded Biomedical Research Centre based at GSTT NHS Foundation Trust. Investigators also received support from the Wellcome Trust, the MRC, BHF, EU, NIHR, CDRF, and the NIHR-funded BioResource, Clinical Research Facility and BRC based at GSTT NHS Foundation Trust in partnership with KCL.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:COVIDCollab project service evaluation approved by Guy's and St Thomas' NHS Trust audit leads. Reference number 10777. The Covid Symptom Study App Ethics has been approved by KCL ethics Committee REMAS ID 18210, review reference LRS-19/20-18210. All subscribers provided consent when signing up for the app.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCOVIDCollab data is available upon application to the Geriatric Medicine Research Collaborative https://www.gemresearchuk.com/. App data used in this study is available to bona fide researchers through UK Health Data Research using the following link https://healthdatagateway.org/detail/9b604483-9cdc-41b2-b82c-14ee3dd705f6 https://www.gemresearchuk.com/. https://healthdatagateway.org/detail/9b604483-9cdc-41b2-b82c-14ee3dd705f6